Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Schermuly

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The European Respiratory Journal|May 10, 2002
Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: responders versus nonrespondersH A Ghofrani, R Wiedemann, F Rose, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 10, 2001
NO and reactive oxygen species are involved in biphasic hypoxic vasoconstriction of isolated rabbit lungsN Weissmann, S Winterhalder, M Nollen, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 10, 2001
Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formationR T Schermuly, A Günther, M Ermert, et al.
The European Respiratory Journal|December 2, 2008
Regulation of hypoxic pulmonary vasoconstriction: basic mechanismsN Sommer, A Dietrich, R T Schermuly, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchangeR T Schermuly, A Roehl, N Weissmann, et al.
The European Respiratory Journal|February 26, 2004
Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertensionH A Ghofrani, G Friese, T Discher, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2010
Inflammation, immunological reaction and role of infection in pulmonary hypertensionS S Pullamsetti, R Savai, W Janssen, et al.
The European Respiratory Journal|June 14, 2008
Shroom expression is attenuated in pulmonary arterial hypertensionJ Sevilla-Pérez, M Königshoff, G Kwapiszewska, et al.
Thrombosis and Haemostasis|September 19, 2014
Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatmentC Veith, D Zakrzewicz, B K Dahal, et al.
The European Respiratory Journal|June 8, 2010
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertensionV S Nikam, R T Schermuly, R Dumitrascu, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The European Respiratory Journal|May 10, 2002
Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: responders versus nonrespondersH A Ghofrani, R Wiedemann, F Rose, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 10, 2001
NO and reactive oxygen species are involved in biphasic hypoxic vasoconstriction of isolated rabbit lungsN Weissmann, S Winterhalder, M Nollen, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 10, 2001
Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formationR T Schermuly, A Günther, M Ermert, et al.
The European Respiratory Journal|December 2, 2008
Regulation of hypoxic pulmonary vasoconstriction: basic mechanismsN Sommer, A Dietrich, R T Schermuly, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchangeR T Schermuly, A Roehl, N Weissmann, et al.
The European Respiratory Journal|February 26, 2004
Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertensionH A Ghofrani, G Friese, T Discher, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2010
Inflammation, immunological reaction and role of infection in pulmonary hypertensionS S Pullamsetti, R Savai, W Janssen, et al.
The European Respiratory Journal|June 14, 2008
Shroom expression is attenuated in pulmonary arterial hypertensionJ Sevilla-Pérez, M Königshoff, G Kwapiszewska, et al.
Thrombosis and Haemostasis|September 19, 2014
Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatmentC Veith, D Zakrzewicz, B K Dahal, et al.
The European Respiratory Journal|June 8, 2010
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertensionV S Nikam, R T Schermuly, R Dumitrascu, et al.
Pageof 4